pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
Companies
by activity
Most Active
Biggest Pipelines
Recently Active
hiring
Companies Hiring Now
Big Pharma Roles
All Companies →
Drugs & Pipeline
intelligence
Drugs
Patent Cliff
research
Publications
Topics
Calendar
window
Next 90 Days
All (incl. Past)
by type
PDUFAs
Approvals
Earnings
Readouts
◐
Sign In
Subscribe
🐶
home
jobs
news
cal
search
Approval · news · pharmadog
← back to Approval
News · Approval
14
stories
Apr 24, 26
Sanofi MS drug rejected in US gets an endorsement in Europe
biopharma dive
Apr 24, 26
Novartis pulls Pluvicto prostate cancer label expansion filing in the EU
endpoints
Apr 24, 26
International childhood vaccine campaign grows
stat
Apr 24, 26
STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and more
stat
Apr 24, 26
STAT+: Sanofi MS drug gets positive review in Europe following FDA
stat
Apr 24, 26
Sanofi’s tolebrutinib gets CHMP backing for certain MS patients despite FDA rejection
endpoints
Apr 23, 26
STAT+: Trump celebrates closing first round of drug pricing deals, promises more ahead
stat
Apr 23, 26
FDA approves Regeneron’s hearing loss gene therapy
biopharma dive
Apr 23, 26
FDA approves Regeneron's hearing loss gene therapy Otarmeni
endpoints
Apr 23, 26
STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy
stat
Apr 23, 26
Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs
biopharma dive
Apr 22, 26
Revolution drug shows promise in early pancreatic cancer
biopharma dive
Apr 22, 26
Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial
biopharma dive
Apr 22, 26
Merck adds to pharma’s AI push; Roche details MS drug results
biopharma dive
